Projected 2020 revenue for top drugs approved in U.S. 2015

Published by Statista Research Department, Mar 30, 2016
This statistic displays the projected 2020 revenue for top drugs approved in the U.S. in 2015. Entresto, approved on July 7, 2015, and developed by Swiss company Novartis, is estimated to generate 2.48 billion U.S. dollars of revenue in 2020.

Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2016

Region

United States

Survey time period

2015 and 2016

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Biotechnology in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology in Spain

Global overview

6

Main figures

6

Companies

6

Areas of application

6

R&D investment

6

Funding

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in SpainGlobal pharmaceutical industryBiotech drugsBiotechnology industry in Germany Biotechnology in Europe
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.